These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 15151376)
1. Primary prevention of type 2 diabetes: how do we do it? Abdul-Ghani MA; Sabah M; Minuchin O; Vardi P; Raz I; Wainstein J Isr Med Assoc J; 2004 May; 6(5):305-7. PubMed ID: 15151376 [No Abstract] [Full Text] [Related]
2. [Prevention by life style intervention and medication. To run away from type 2 diabetes]. Wepner U MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745 [No Abstract] [Full Text] [Related]
3. [Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?]. Laakso M Duodecim; 2003; 119(20):1921-3. PubMed ID: 14639996 [No Abstract] [Full Text] [Related]
4. Prevention of type 2 diabetes in the prediabetic population. Maji D; Roy RU; Das S J Indian Med Assoc; 2005 Nov; 103(11):609-11. PubMed ID: 16570766 [TBL] [Abstract][Full Text] [Related]
5. [Delaying and preventing type 2 diabetes mellitus]. Mehnert H MMW Fortschr Med; 2003 Mar; 145(12):51-4. PubMed ID: 15106701 [TBL] [Abstract][Full Text] [Related]
6. [Acarbose can slow down beginning of type 2 diabetes]. Lanzendörfer C Dtsch Med Wochenschr; 2003 Jan; 128(4):162; discussion 162. PubMed ID: 12589591 [No Abstract] [Full Text] [Related]
7. [Primary prevention of diabetes mellitus type 2]. Gallwitz B Internist (Berl); 2004 Jun; 45 Suppl 1():S15-22. PubMed ID: 15241504 [TBL] [Abstract][Full Text] [Related]
8. [Screening, prevention and early therapy of type 2 diabetics]. Hanefeld M; Köhler C MMW Fortschr Med; 2004 Sep; 146(35-36):28-9, 31. PubMed ID: 15540535 [TBL] [Abstract][Full Text] [Related]
10. [Treatment for patients with impaired glucose tolerance]. Tawaramoto K; Kaku K Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416 [No Abstract] [Full Text] [Related]
11. [Primary prevention of type 2 diabetes mellitus according to lifestyle intervention--the process and for the future]. Kosaka K Nihon Rinsho; 2002 Sep; 60 Suppl 9():52-99. PubMed ID: 12386979 [No Abstract] [Full Text] [Related]
12. [In high risk for diabetes should drugs be used for prevention? (interview by Dr. Judith Neumaier)]. Hanefeld M MMW Fortschr Med; 2002 Oct; 144(40):12. PubMed ID: 12440285 [No Abstract] [Full Text] [Related]
13. [Optimal drug therapy of glucose intolerance is a guarantee of successful prevention of type 2 diabetes mellitus]. Mkrtumian AM Ter Arkh; 2002; 74(12):86-9. PubMed ID: 12577852 [No Abstract] [Full Text] [Related]
14. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada. Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090 [TBL] [Abstract][Full Text] [Related]
15. [Primary prevention of diabetes mellitus by pharmacological intervention]. Noda M Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980 [No Abstract] [Full Text] [Related]
16. [Cardioprotection by acarbose--pro]. Breuer HW Dtsch Med Wochenschr; 2004 May; 129(20):1155. PubMed ID: 15143459 [No Abstract] [Full Text] [Related]
18. [Cardioprotection by acarbose--contra]. Kaiser T; Sawicki PT Dtsch Med Wochenschr; 2004 May; 129(20):1156. PubMed ID: 15143460 [No Abstract] [Full Text] [Related]
19. Pharmacologic prevention or delay of type 2 diabetes mellitus. Anderson DC Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143 [TBL] [Abstract][Full Text] [Related]
20. Acarbose for type 2 diabetes prevention. Mühlhauser I Lancet; 2002 Nov; 360(9344):1517; author reply 1517. PubMed ID: 12433559 [No Abstract] [Full Text] [Related] [Next] [New Search]